In early 2002, the Food and Drug Administration (FDA) approved Prempro, also known as Premphase, for the treatment of vasomotor symptoms associated with the menopause and vulvar and vaginal atrophy as well as for the prevention of postmenopausal osteoporosis. Prempro is manufactured by Wyeth, the pharmaceuticals and medicines giant that produces well-known drugs like Advil, Centrum, and Robitussin. The Women's Health Initiative lead a 2002 study of Prempro to assess whether long-term use of Prempro reduces the risk of coronary heart disease (CHD) in postmenopausal women. The study found an increased risk of CHD, and also a large increase in the risk for invasive breast cancer. Researchers halted the study after deciding that the overall health risks of Prempro exceeded the benefits of the drug.
The FDA has required Prempro to add a new boxed warning stating that Prempro should not be prescribed to postmenopausal women for cardiovascular protection and that estrogen plus progestin therapies should be prescribed for the shortest duration possible under a person's individual treatment goals. Prempro continues to remain on the market, but the FDA has continued to caution potential users while it investigates further whether the drug should be completely withdrawn from the market. If you or a loved one has taken Prempro, also known as conjugated estrogens/medroxyprogesterone acetate tablets, we will evaluate your case absolutely free. If Prempro has injured you or a loved one, our legal team will aggressively fight for your rights. You may be entitled to compensation.
|
The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use. |